SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dishman Pharmaceuticals and Chemicals board declares interim dividend

10 Mar 2016 Evaluate

Dishman Pharmaceuticals and Chemicals has informed that the Board of Directors of the Company at its meeting held on March 10, 2016, has declared an Interim dividend of Rs 2.00 (i.e. at the rate of 100%) per equity share on 80,697,136 equity shares of Rs 2.00 each of the Company for the financial year 2015-2016. The interim dividend shall be paid to the members entitled thereto, on and from March 22, 2016. The Dividend cheques/warrants would be posted on or after March 22, 2016 and within 30 days from the date of declaration of interim dividend as provided in the Companies Act, 2013.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×